Please assess the completion status of the following clinical trial:

Trial Title: Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with one or more symptom of overactive bladder, including urge urinary incontinence, urgency and/or frequency~Exclusion Criteria:~* Patients for whom Oxytrol(r) is contraindicated.~* Patients treated with Oxytrol(r) prior to participation in this study.~* Patients residing in long-term care facilities or nursing homes.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).